Company Name, Ticker, Industry, else..
STOCKS
HOME
Stock Profile
Company Fundamentals
Financial Results
CDTX's Officers & Directors
Company Descriptions
Charts & Quotes
News
Company Suppliers
Company Competitors
Company Markets Customers
Economic Indicators
INDUSTRIES
Revenue Growth by Industry
Net Income Growth by Industry
Net Margin by Industry
PE by Industry
Total Debt to Equity by Industry
Revenue per Employee by Industry
Return On Assets by Industry
Performance by Industry
Growth Rates by Industry
Profitability by Industry
Valuation by Industry
Financial Strength by Industry
ECONOMY
Advance Monthly Sales
Consumer Price Index CPI
Producer Price Index PPI
Retail Inventories
Personal Income
Gross Domestic Product GDP
Money Supply
Industrial Production
Productivity
Employment Situation
U.S. International Trade
Factory orders
Durable Goods
Construction Spending
Housing Starts
Vehicle Unit Sales
MARKETS
Stocks
Cryptocurrencies
Sectors & Industries
Commodities
Foreign Exchange
Stocks in 2023
SCREENING
Stock Performance Screening
Profitability Screening
Valuation Screening
Dividend Screening
Financial Strength Screening
Efficiency Screening
Largest Companies
Mgmnt. Effectivness Screening
NEWS
Stock News
Economy News
GLOSSARY
Financial Terms
Technical Analysis
Fundamental Analysis
Energy Terms
Manufacturing Terms
Transportation Terms
Health Care
Insurance Terms
Economy Terms
Hotel & Leisure Terms
HELP
Company Profile
Cidara Therapeutics Inc News
Cidara Therapeutics Inc's Net Profit Margin
Cidara Therapeutics Inc's Net Profit Margin
Cidara Therapeutics Inc Business Description
Cidara Therapeutics Inc Executive Officers
Economic Indicators
Fundamentals
Cidara Therapeutics Inc Growth Rates
Cidara Therapeutics Inc Profitability
Cidara Therapeutics Inc Valuation
Cidara Therapeutics Inc Management Effectiveness
Cidara Therapeutics Inc Financial Strength
Cidara Therapeutics Inc Efficiency
Cidara Therapeutics Inc Dividend
Financials
Cidara Therapeutics Inc Business Segments
Cidara Therapeutics Inc Income Statement
Cidara Therapeutics Inc Balance Sheets
Cidara Therapeutics Inc Cash Flow Statement
Cidara Therapeutics Inc Geographic Information
Suppliers
Cidara Therapeutics Inc Suppliers Performance
CDTX Suppliers Stock Performance
CDTX Suppliers Growth Rates
CDTX Suppliers Data
CDTX Suppliers Efficiency
CDTX Suppliers Management Effectiveness
CDTX Suppliers Valuation
CDTX Suppliers by Companys' Segments
Competition
Competition by Companys' Segments
Cidara Therapeutics Inc Market Share
Cidara Therapeutics Inc Competition Performance
Cidara Therapeutics Inc Competitors Results
CDTX Competitors Stock Performance
CDTX Competitors Growth Rates
CDTX Workforce Efficiency at the Competitors
CDTX Competitors Efficiency
CDTX Competitors Management Effectiveness
CDTX Competitors Valuation
Customers & Markets
Cidara Therapeutics Inc Customers Demand
CDTX Customers Expenditure Growth Rates
CDTX Customers Performance
CDTX Customers Stock Performance
CDTX Customers Growth Rates
CDTX Workforce Efficiency at the Customers
CDTX Customers Efficiency
CDTX Customers Management Effectiveness
CDTX Customers Valuation
CDTX Customers by Companys' Segments
Charts & Quotes
Cidara Therapeutics Inc Comparison Charts
CDTX OHLC Charts
CDTX's Tehnical Upper Indicators
CDTX's Tehnical Lower Indicators
CDTX's Weekly Charts
CDTX's Monthly Charts
Cidara Therapeutics Inc's Profile
Company Charts and Quotes
Cidara Therapeutics Inc News
Cidara Therapeutics Inc's Business Segments
Cidara Therapeutics Inc's Income Statement
Cidara Therapeutics Inc's Balance Sheets
Cidara Therapeutics Inc's Cash Flow Statement
Cidara Therapeutics Inc's Profitability
Cidara Therapeutics Inc's Financials
CDTX's ROE Quarterly
Cidara Therapeutics Inc's Suppliers
Cidara Therapeutics Inc's Competitors
Cidara Therapeutics Inc's Markets & Customers
Cidara Therapeutics Inc's Market Share
CDTX's Suppliers Management Effectiveness
CDTX's Employee Efficiency at the Competitors
CDTX's Charts Williams %R
Cidara Therapeutics Inc's Customers Performance
Economic Indicators
Profitability by Industry
List of the Largest Companies
Markets at a Glance
Stocks
Cryptocurrencies
Sectors & Industries
Commodities
Foreign Exchange
Stocks in 2023
Construction Spending
News
Economy News
Stock News
Insurance Terms
At a Glance
Growth Rates
• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• F. Cash Flow Y/Y Annual
Profitability
Valuation Comparisons
Management Effectiveness
Financial Strength
Efficiency
Dividend Comparisons
Cidara Therapeutics Inc
(
CDTX
)
Other Ticker:
Sector
•
Healthcare
Industry
•
Biotechnology & Pharmaceuticals
Industry
•
Biotechnology & Pharmaceuticals
Sector
•
Healthcare
Cidara Therapeutics Inc 's Yearly Free Cash Flow Growth 5 Years
Select the Comparisons :
None ▼
Growth Rates
Profitability
Valuation Comparisons
Management Effectiveness
Financial Strength
Efficiency
Dividend Comparisons
Select the Ratio:
Annual Free Cash Flow Annual Growth Rates Y/Y▼
Revenue Y/Y
Op. Income Y/Y
Income from Cont. Operations Y/Y
Net Income Y/Y
Effective Tax Rate
Eps Cop. Y/Y
Eps Net Y/Y
Free Cash Flow Y/Y
Cash Flow Y/Y
Capex Y/Y
Gross Margin
EBITDA Margin
Operating Margin
Net Margin
Pre-Tax Margin
Free Cash Flow Margin
Cash Flow Margin
P/E Ratio TTM
P/S Ratio TTM
P/CF Ratio TTM
P/FCF Ratio TTM
Price to Book MRQ
Price to Tangible Book
ROA Quarterly
ROI Quarterly
ROE Quarterly
Quick Ratio
Quick Ratio TTM
Working Capital
Working Capital TTM
Long Term Debt to Equity
Long Term Debt to Equity TTM
Debt to Equity
Debt to Equity TTM
Leverage Ratio
Leverage Ratio TTM
Tangible Leverage Ratio
Interest Coverage
Debt Coverage
Working Capital Per Revenue
Sales per Employee
Income per Employee
Inventory to Sales
Inventory Turnover
Asset Turnover
Receivables Turnover
Dividend Growth
Dividend Payout
Cumulative Payout
Annual Dividend Payout
Revenue Annual Growth
Operating Income Annual Growth
Income from Continued Operations Annual Growth
Net Income Annual Growth
Eps Continued Operations Annual Growth
Eps Net Annual Growth
Free Cash Flow Annual Growth
Cash Flow Annual Growth
Capex Annual Growth
None ▼
Growth Rates
Profitability
Valuation Comparisons
Management Effectiveness
Financial Strength
Efficiency
Dividend Comparisons
Annual Free Cash Flow Annual Growth Rates Y/Y▼
Revenue Y/Y
Op. Income Y/Y
Income from Cont. Operations Y/Y
Net Income Y/Y
Effective Tax Rate
Eps Cop. Y/Y
Eps Net Y/Y
Free Cash Flow Y/Y
Cash Flow Y/Y
Capex Y/Y
Gross Margin
EBITDA Margin
Operating Margin
Net Margin
Pre-Tax Margin
Free Cash Flow Margin
Cash Flow Margin
P/E Ratio TTM
P/S Ratio TTM
P/CF Ratio TTM
P/FCF Ratio TTM
Price to Book MRQ
Price to Tangible Book
ROA Quarterly
ROI Quarterly
ROE Quarterly
Quick Ratio
Quick Ratio TTM
Working Capital
Working Capital TTM
Long Term Debt to Equity
Long Term Debt to Equity TTM
Debt to Equity
Debt to Equity TTM
Leverage Ratio
Leverage Ratio TTM
Tangible Leverage Ratio
Interest Coverage
Debt Coverage
Working Capital Per Revenue
Sales per Employee
Income per Employee
Inventory to Sales
Inventory Turnover
Asset Turnover
Receivables Turnover
Dividend Growth
Dividend Payout
Cumulative Payout
Annual Dividend Payout
Revenue Annual Growth
Operating Income Annual Growth
Income from Continued Operations Annual Growth
Net Income Annual Growth
Eps Continued Operations Annual Growth
Eps Net Annual Growth
Free Cash Flow Annual Growth
Cash Flow Annual Growth
Capex Annual Growth
CDTX Annual Free Cash Flow Growth
2022
2021
2020
2019
2018
Y / Y Annual Free Cash Flow Change
-
-
-
-
-
Annual Free Cash Flow (in millions $)
$-28.59
$-25.27
$-54.60
$-28.57
$-56.88
CDTX Company Profile
>>
Back to CDTX Fundamentals at a Glance
>>
Back to CDTX Growth Comparisons
Annual Free Cash Flow Growth Comment
Cidara Therapeutics Inc
realized free cash outflow.
Cidara Therapeutics Inc Annual Income Statement
You need to upgrade your Flash Player
Companies with similar 2022 Annual Free Cash Flow within Healthcare Sector
Y/Y Free Cash Flow Growth %
2022 Annual Free Cash Flow
Align Technology inc
-64.12 %
$ 276.832 millions
Resmed Inc
-68.53 %
$ 195.111 millions
Teleflex Incorporated
-54.59 %
$ 263.616 millions
Arvinas Inc